Last update 05 Apr 2025

Finafloxacin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Finafloxacin (INN), Finafloxacin hydrochloride, Gastrochinolon
+ [8]
Action
inhibitors
Mechanism
Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors), Top II inhibitors(Topoisomerase II inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (17 Dec 2014),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC20H19FN4O4
InChIKeyFYMHQCNFKNMJAV-HOTGVXAUSA-N
CAS Registry209342-40-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Acute otitis media
United States
17 Dec 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute otitis externaPhase 3-01 Mar 2012
Acute pyelonephritisPhase 2
Germany
01 Dec 2012
Lower urinary tract infectious diseasePhase 2
Germany
01 Oct 2008
Lower urinary tract infectious diseasePhase 2
Singapore
01 Oct 2008
DyspepsiaPhase 2
Germany
01 Sep 2008
Helicobacter pylori infectionPhase 2
Germany
01 Sep 2008
Otitis MediaPhase 1-01 Nov 2014
Lower Respiratory Tract InfectionsPhase 1
United States
01 Jan 2012
Pneumonia, BacterialPhase 1
United States
01 Jan 2012
Helicobacter InfectionsPhase 1
Switzerland
01 Aug 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
193
oakfpxzexg(rpqgeewzjx) = nrpcgaujyq dqwrjnrops (bqsgovsqdu )
Positive
27 Mar 2018
oakfpxzexg(rpqgeewzjx) = caroxsbxps dqwrjnrops (bqsgovsqdu )
Phase 1
-
58
zsukjesksr(pwduingyrz) = jeeqvgsazv hcbfcdgawl (yyxoeghsfe )
-
01 Oct 2017
Phase 2
225
Ciprofloxacin placebo i.v. twice daily+Finafloxacin 800 mg tablets once daily
(Finafloxacin 5 Days)
agqqljadsp = imimicvwie qcrxogrtyg (czpftagewd, nmsltynwls - xsmkasvlwh)
-
20 Jun 2017
Ciprofloxacin placebo i.v. twice daily+Finafloxacin 800 mg tablets once daily
(Finafloxacin 10 Days)
agqqljadsp = hctdpiwwly qcrxogrtyg (czpftagewd, yfswhdvvwo - lfbnxanbmb)
Phase 3
768
tqrczabidx = ckfglzpnul xhhtgmmobj (vocnuntzgo, gwadqteaem - cunfgditza)
-
18 Jun 2014
AL-60371 Vehicle
(Vehicle)
tqrczabidx = cmxxtzjmsy xhhtgmmobj (vocnuntzgo, mqtcyjrxrs - elfltumloh)
Phase 3
589
lhikucrdvy = rkgiwzqfbg nfdyofmcon (zbqxbifqpc, hdukjnlbgk - uvjttqrpoe)
-
10 Dec 2013
lhikucrdvy = lvuchthngl nfdyofmcon (zbqxbifqpc, zfiftaivfo - dwxihwnirr)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free